Post-translational modifications of naturally processed MHC-binding epitopes
- PMID: 16343885
- DOI: 10.1016/j.coi.2005.11.015
Post-translational modifications of naturally processed MHC-binding epitopes
Abstract
A variety of different post-translational modifications of peptides displayed by class I and II MHC molecules have now been described. Some modifications promote the binding of peptides to MHC molecules, and might also influence the ability of the peptide to be produced by antigen processing pathways. In some instances, the antigen processing components themselves are actually responsible for generating post-translational modifications. Finally, evidence is accumulating that modifications can be altered as a consequence of inflammation, transformation, apoptosis and aging. This leads to altered repertories of MHC-associated peptides, which may be important in immune responses associated with autoimmune diseases, infection and cancer.
Similar articles
-
No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.Eur J Immunol. 2007 Apr;37(4):896-904. doi: 10.1002/eji.200636372. Eur J Immunol. 2007. PMID: 17357105
-
Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells.Eur J Immunol. 2006 Mar;36(3):544-57. doi: 10.1002/eji.200526235. Eur J Immunol. 2006. PMID: 16479539
-
Post-translational modifications of self antigens: implications for autoimmunity.Curr Opin Immunol. 2004 Dec;16(6):753-8. doi: 10.1016/j.coi.2004.09.001. Curr Opin Immunol. 2004. PMID: 15511669 Review.
-
Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.Br J Dermatol. 2008 May;158(5):930-40. doi: 10.1111/j.1365-2133.2008.08465.x. Epub 2008 Feb 16. Br J Dermatol. 2008. PMID: 18284388
-
All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway.Immunol Rev. 2005 Oct;207:31-41. doi: 10.1111/j.0105-2896.2005.00321.x. Immunol Rev. 2005. PMID: 16181325 Review.
Cited by
-
Variations in MHC class I antigen presentation and immunopeptidome selection pathways.F1000Res. 2020 Sep 28;9:F1000 Faculty Rev-1177. doi: 10.12688/f1000research.26935.1. eCollection 2020. F1000Res. 2020. PMID: 33014341 Free PMC article. Review.
-
Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.Front Immunol. 2022 Apr 8;13:873947. doi: 10.3389/fimmu.2022.873947. eCollection 2022. Front Immunol. 2022. PMID: 35464453 Free PMC article.
-
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complex.JCI Insight. 2022 Mar 8;7(5):e151624. doi: 10.1172/jci.insight.151624. JCI Insight. 2022. PMID: 35260532 Free PMC article.
-
Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.PLoS One. 2014 Nov 7;9(11):e112467. doi: 10.1371/journal.pone.0112467. eCollection 2014. PLoS One. 2014. PMID: 25379761 Free PMC article.
-
HLA-B and cysteinylated ligands distinguish the antigen presentation landscape of extracellular vesicles.Commun Biol. 2021 Jul 1;4(1):825. doi: 10.1038/s42003-021-02364-y. Commun Biol. 2021. PMID: 34211107 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials